• Policy
• The regulation for shortening the period will be revised
• by Lee, Hye-Kyung Aug 16, 2022 05:46am

• Policy
• The Price of 4 Xarelto will be cut from the 22nd as planned
• by Kim, Jung-Ju Aug 12, 2022 05:58am

• Policy
• CKD completes acquiring 3 exclusive licensed items
• by Lee, Tak-Sun Aug 12, 2022 05:58am

• Policy
• Ceprotin, Takeda's rare dz, gives 11 yrs for reexamination
• by Lee, Hye-Kyung Aug 12, 2022 05:57am

• Policy
• Gov is reluctant to demand that infants be exempted from PE
• by Lee, Jeong-Hwan Aug 11, 2022 06:03am

• Policy
• Reyvow, a migraine drug aimed at clinicians
• by Lee, Tak-Sun Aug 11, 2022 06:03am

• Policy
• "May bring 60M courses of Omicron-adapted COVID-19 vaccines"
• by Lee, Jeong-Hwan Aug 11, 2022 06:03am

• Policy
• Will approval of brain function enhancers be revoked?
• by Lee, Hye-Kyung Aug 10, 2022 05:53am

• Policy
• AZ seeks reimb of its triple inhaled therapy for COPD
• by Lee, Tak-Sun Aug 10, 2022 05:52am

• Policy
• When replacing Spinraza→Zolgensma, it should be injected
• by Lee, Hye-Kyung Aug 10, 2022 05:52am